WNV in Blood, Ramifications for Blood Donations (4) (Modified by Lois Levitan)

Transcripts for the meeting (Discussion on West Nile Virus - Blood
Products Advisory Committee Meeting - July 22-23, 2004) are available
on the FDA website at the following URL:

<http://www.fda.gov/ohrms/dockets/ac/acmenu.htm>

The Blood Products Advisory Committee will be meeting again on October
21-22, 2004. On October 22nd, it is expected to be a follow-up
discussion
on WNV. More details regarding the specific agenda will be available
shortly.

Linda A. Smallwood

Linda A. Smallwood, Ph.D.
Associate Director for Policy, OBRR, CBER, FDA
Executive Secretary, Blood Products Advisory Committee
1401 Rockville Pike, HFM-302
Rockville, MD 20852
(301) 827-3514, FAX: (301) 827-2843
smallwood@cber.fda.gov

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
WESTNILEVIRUS-L is an email discussion group for communication
and discussion about West Nile Virus, particularly regarding policy,
risk reduction and public education issues. It is moderated by
Dr. Lois Levitan, Program Leader of the Cornell University
Environmental Risk Analysis Program (ERAP).
To subscribe (or unsubscribe), send an email request with your name
and contact information to <envrisk@cornell.edu>.
To receive messages once a day in digest format, subscribers can
send an email to <listproc@cornell.edu> with message:
"set WESTNILEVIRUS-L mail digest-nomime".

Subscribers are encouraged to post to the group by sending
messages to <envrisk@cornell.edu>. Put "WNV Listserv" in
the subject line and send unformatted text, without attachments.
------------------------------------------------------------------------
---------------------
Received on Fri Aug 27 15:26:05 2004